Skip to main content
Veterinary Medicines

Bovilis Bovipast RSP suspensija injekcijām liellopiem

Authorised
  • Bovine respiratory syncytial virus, strain EV 908, Inactivated
  • Bovine parainfluenza virus 3, strain SF-4, Inactivated
  • Mannheimia haemolytica, serotype A1, strain M4/1, Inactivated

Product identification

Medicine name:
Bovilis Bovipast RSP suspensija injekcijām liellopiem
Active substance:
  • Bovine respiratory syncytial virus, strain EV 908, Inactivated
  • Bovine parainfluenza virus 3, strain SF-4, Inactivated
  • Mannheimia haemolytica, serotype A1, strain M4/1, Inactivated
Target species:
  • Cattle
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Bovine respiratory syncytial virus, strain EV 908, Inactivated
    2511890.00
    tissue culture infective dose 50
    /
    1.00
    unit(s)
  • Bovine parainfluenza virus 3, strain SF-4, Inactivated
    199526000.00
    tissue culture infective dose 50
    /
    1.00
    unit(s)
  • Mannheimia haemolytica, serotype A1, strain M4/1, Inactivated
    9000000000.00
    cells
    /
    1.00
    unit(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • Not specified
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AL04
Authorisation status:
  • Valid
Authorised in:
  • Latvia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • Food And Veterinary Service
Authorisation number:
  • V/NRP/05/1660
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 4/04/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."